Results 201 to 210 of about 1,294,431 (344)

Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia. [PDF]

open access: yesJ Immunother Cancer
Liu Y   +15 more
europepmc   +1 more source

CASE OF LYMPHATIC LEUKEMIA [PDF]

open access: green, 1909
H. H. Hazen
openalex   +1 more source

Gastrula‐Premarked Posterior Enhancer Primes Posterior Tissue Development Through Cross‐Talk with TGF‐β Signaling Pathway

open access: yesAdvanced Science, EarlyView.
A gastrula‐premarked enhancer within the first intron of Cdx2 governs posterior embryonic development via both regulating Cdx2 expression in cis and coordinating TGF‐β signaling in trans to ensure proper posterior body development. Functional rescue in gastruloids reveals a Cdx2‐independent pathway, highlighting p‐Enh‐eRNA as key epigenetic ...
Yingying Chen   +16 more
wiley   +1 more source

P1590: OUTCOME OF HYPERBARIC OXYGEN THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES –A TERTIARY CANCER CENTER EXPERIENCE

open access: yesHemaSphere, 2022
K. Kim   +7 more
doaj   +1 more source

Aleukemic Stem Cell Leukemia with Polyserositis [PDF]

open access: bronze, 1955
Arthur H. Raynolds   +2 more
openalex   +1 more source

Advanced Microfluidics for Single Cell‐Based Cancer Research

open access: yesAdvanced Science, EarlyView.
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro   +10 more
wiley   +1 more source

Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity

open access: yesBlood Cancer Journal
Isolde Summerer   +12 more
doaj   +1 more source

The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms

open access: yesHaematologica, 2018
Manja Meggendorfer   +4 more
doaj   +1 more source

P763: VENETOCLAX WITH AZACITIDINE IN RELAPSE/REFRACTORY HIGHER RISK MYELODYSPLASTIC SYNDROME: UPDATED PHASE 1 RESULTS

open access: yesHemaSphere, 2022
S. P. Desikan   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy